May 19, 2005 -- The results of the trial were that the study found significant improvements in reported wellbeing, asthma symptoms and ability to exercise. There were no consistent,
statistically significant changes in other surveyed subjective measures, spirometry measures or diary entries.
Asthma has profound effects on patients, their families and the community. Poorly controlled asthma can reduce patients' wellbeing, and interfere with their ability to exercise and to
participate in sport and community activities.
Oralmat taken as a supplement could help many asthma sufferers lead a more active, normal life and reduce the enormous costs of hospitalization.
Further trials are scheduled to be carried out with Oralmat on asthma sufferers which the manufacturers, Schumacher Pharmaceuticals, are confident will show that this pollen free, gluten
free rye extract will prove to be an essential part of any asthma sufferers regime.
Contact:
Darren Gould
0845 838 2719
e-mail protected from spam bots